세계 자동조제기 시장은 2023년 50억 6,000만 달러에 달했고, 2031년에는 86억 2,000만 달러에 달할 것으로 예상되며, 2024-2031년간 6.9%의 연평균 복합 성장률(CAGR)을 나타낼 것으로 전망됩니다.
자동조제기(ADM)는 통제된 방식으로 약물을 조제하도록 설계된 첨단 전산화 장비로, 수동 조제 과정과 관련된 오류의 위험을 크게 최소화합니다. 의료 기관은 약물 관리에 기술을 도입함으로써 업무 효율성을 개선하는 동시에 환자의 안전과 만족도를 보장할 수 있습니다.
자동조제기(ADM)는 환자 치료실에서 안전한 약품 보관을 가능하게 하고, 인적 오류를 최소화하고 라벨링 오류 및 잘못된 투약량을 줄여 조제 정확도를 높이며, 바코드 스캐닝 및 컴퓨터 추적과 같은 첨단 기술을 통해 올바른 환자에게 올바른 약품이 제공될 수 있도록 합니다. 바코드 스캐닝, 컴퓨터 추적 등의 첨단 기술이 탑재되어 있어 정확한 환자에게 정확한 약물을 제공할 수 있습니다.
성장 촉진요인과 저해요인
의료 과실 증가
의료 실수 발생률 증가는 자동조제기 시장을 견인할 것으로 예상됩니다. 투약 오류는 환자 안전에 심각한 위험을 초래하기 때문에 의료 서비스 제공업체는 조제 정확도를 향상시키는 솔루션을 추구하고 있습니다.
의료 실수를 줄이기 위해 의료 서비스 제공 업체는 여러 가지 자동 조제 솔루션을 채택하고 있으며, 이는 시장을 주도할 것으로 예상되며, 2023년 국립 보건 연구소의 발표에 따르면, ADC와 기존 병동 재고를 비교한 스위스 연구에 따르면 ADC는 조제 실수를 5%에서 1%로 크게 줄였습니다고 합니다.에서 1%로 크게 줄일 수 있는 것으로 나타났습니다고 언급했습니다. 대만에서 진행된 또 다른 연구에 따르면 ADC가 처방전만 조제하는 데 사용되었음에도 불구하고 ADC를 채택한 후 조제 실수가 75% 감소한 것으로 나타났습니다.
기술 혁신, 특히 자동조제기(ADM)는 이러한 오류를 최소화할 수 있는 능력을 향상시키고 있습니다. 첨단 분석 및 머신러닝 기능과 같은 기능이 ADM에 통합되면서 안전하고 정확한 투약을 보장하는 데 있어 ADM의 효율성이 더욱 향상되고 있습니다.
의료 실수를 줄이는 자동 조제 시스템의 기술 발전이 계속되고 있습니다. 각 업체들은 고객에게 효율적인 솔루션을 제공하기 위해 솔루션을 발전시키고 있습니다. 예를 들어, 2024년 4월 옴니셀은 고객의 의료시설에 기존 XT 자동 조제 시스템을 강화하여 현재의 약국 의료 서비스 제공 모델을 최적화하는 것을 목표로 하는 다년간의 혁신 프로젝트인 XT Amplify를 시작했습니다.
2023년 10월, JVM과 한미사이언스는 로봇팔을 탑재한 차세대 자동조제기를 독자적으로 개발하여 유럽 시장에서 판매를 시작했습니다. 또한, JVM은 네덜란드 Brocacef사와 공급 계약을 체결했다고 밝혔습니다.
고액의 초기 투자비용
자동조제기 도입이 직면한 주요 과제 중 하나는 구매 및 도입에 많은 초기 투자가 필요하다는 것입니다. 이러한 시스템에는 하드웨어 구매뿐만 아니라 소프트웨어 통합 및 설치 비용 등 많은 초기 비용이 소요되는 것이 일반적입니다. 소규모 의료 시설이나 약국, 특히 예산이 부족한 소규모 의료 시설이나 약국에서는 이러한 투자에 필요한 자금을 할당하는 데 어려움을 겪을 수 있습니다. 이러한 경제적 부담은 첨단 약물 관리 솔루션을 도입하는 데 걸림돌이 될 수 있습니다.
The global automated dispensing machines market reached US$ 5.06 billion in 2023 and is expected to reach US$ 8.62 billion by 2031, growing at a CAGR of 6.9% during the forecast period 2024-2031.
Automated dispensing machines (ADMs) are advanced computerized devices designed to dispense medications in a controlled manner, greatly minimizing the risk of errors associated with manual dispensing processes. By incorporating technology into medication management, healthcare facilities can improve operational efficiency while simultaneously ensuring patient safety and satisfaction.
Automated dispensing machines provide secure medication storage in patient care units. ADMs enhance the accuracy of medication dispensing by minimizing human error and reducing the risk of mislabeling or incorrect dosages. They are equipped with advanced technologies such as barcode scanning and computerized tracking to ensure that the correct medications are provided to the right patients.
Market Dynamics: Drivers & Restraints
Increasing incidence of medical errors
The increasing incidence of medical errors is expected to drive the automated dispensing machines market. Medication errors present significant risks to patient safety, prompting healthcare providers to pursue solutions that improve the accuracy of medication dispensing.
To reduce medical errors healthcare providers are adopting several automated dispensing solutions that are expected to drive the market. According to the publication in the National Institute of Health in 2023, it is mentioned that according to a Swiss study comparing ADCs with traditional ward stocks found that ADCs can significantly reduce dispensing errors from 5 to 1%. Another study conducted in Taiwan found that dispensing errors were reduced by 75% after the adoption of ADCs, even though ADCs were used to dispense prescriptions with only stat orders.
Innovations in technology, particularly within automated dispensing machines (ADMs), are enhancing their ability to minimize these errors. Features such as advanced analytics and machine learning capabilities are being integrated into ADMs, further increasing their effectiveness in ensuring safe and precise medication administration.
There is a growing technological advancements in automated dispensing systems that reduce medical errors. Companies are advancing their solutions to provide their customers with efficient solutions. For instance, in April 2024, Omnicell launched its XT Amplify, a multi-year innovation project that aims to optimize the current pharmacy care delivery model by enhancing the existing XT Automated Dispensing Systems in their client's healthcare facilities.
In October 2023, JVM, Hanmi Science independently developed and launched a next-generation automated drug dispensing machine equipped with a robotic arm in the European market. JVM further announced that it had entered a supply contract in the Netherlands with Brocacef.
High Initial Investment
One of the primary challenges facing the adoption of automated dispensing machines is the substantial initial investment required for their purchase and implementation. These systems typically entail significant upfront costs, which include not only the acquisition of hardware but also software integration and installation expenses. Smaller healthcare facilities and pharmacies, particularly those operating under tight budget constraints, may struggle to allocate the necessary capital for such an investment. This financial burden can hinder their ability to adopt advanced medication management solutions.
The global automated dispensing machines market is segmented based on type, size end-user, and region.
Decentralized segment is expected to dominate the global automated dispensing machines market share
The decentralized segment is expected to hold the dominant position in the global automated dispensing machines market. This is due to their ability to enhance medication management and improve patient safety. These systems allow medications to be stored closer to the point of care, significantly reducing the time healthcare professionals need to access necessary medications. This rapid availability is particularly crucial in emergencies, where timely medication administration can directly impact patient outcomes.
For instance, studies have shown that hospitals using decentralized automated dispensing cabinets have experienced a reduction in medication administration errors by up to 75%, underscoring the effectiveness of these systems in enhancing patient safety and overall care quality.
North America is expected to hold a significant position in the global automated dispensing machines market share
North America holds a dominant position in the global automated dispensing machines market and is expected to hold the major portion of the market during the forecast period. North America's anticipated dominance in the automated dispensing machines market is driven by high adoption rates of automation, technological innovations, and favorable market growth projections. As healthcare providers continue to recognize the benefits of ADMs in enhancing operational efficiency and improving patient outcomes, the region is poised for sustained growth in this sector.
Increasing technological advancements are expected to drive the region's automated dispensing machines. Market players are innovating advanced solutions that meet the needs and demands of pharmacies and hospitals. For instance, in March 2024, Nordson EFD introduced the new GVPlus and PROX families of automated fluid dispensing products. Both robotic solutions share a focus on motion, workspace, repeatability, payload, setup, and vision technology enhancements.
Additionally, the presence of numerous key players in the region further supports market growth, fostering innovation and competition within the automated dispensing machines landscape.
The major global players in the automated dispensing machines market include Omnicell, Nordson Corporation, Baxter, bdtronic, Capsa Healthcare, TouchPoint Medical, McKesson Medical-Surgical Inc., Swisslog Healthcare, ARxIUM and ScriptPro LLC among others.
The Global Automated Dispensing Machines market report delivers a detailed analysis with 60+ key tables, more than 50 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.
LIST NOT EXHAUSTIVE